Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Qnexa
Qnexa
5 Drugmakers Headed Back to the Drawing Board
Motley Fool
Mon, 01/31/11 - 06:54 pm
Bydureon
Eli Lilly
Amylin
diabetes
MannKind
Afrezza
InterMune
Esbriet
IPF
Lorqess
Arena Pharmaceuticals
Vivus
Qnexa
Arena's Obese To-Do List
Motley Fool
Sat, 01/29/11 - 11:32 am
Arena Pharmaceuticals
Qnexa
Vivus
Rats Plague Arena's Diet Pill
Minyanville
Sat, 01/29/11 - 11:20 am
Arena Pharmaceuticals
Orexigen
obesity
diet drugs
Qnexa
Vivus
Vivus says FDA asks about Qnexa birth defect link
Yahoo/AP
Fri, 01/21/11 - 10:10 am
Qnexa
birth defects
FDA
Vivus
obesity
Vivus applies to market obesity drug Qnexa in EU
Marketwatch
Mon, 12/20/10 - 12:31 pm
Vivus
Qnexa
obesity
EU
Europe
Diet Drug Rally: Orexigen, Vivus, Arena
TheStreet.com
Wed, 12/8/10 - 12:27 pm
obesity
Orexigen
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Diet Drug Optimism Lifts Shares of Vivus
NY Times
Sat, 10/30/10 - 12:14 pm
Vivus
Qnexa
obesity
Vivus Gains on Potential to Win U.S. Clearance for Obesity Drug Next Year
Bloomberg
Fri, 10/29/10 - 11:49 am
Qnexa
FDA
obesity
Vivus
Whither Diet Pills? Why The FDA Keeps Saying No
Pharmalot
Fri, 10/29/10 - 11:46 am
Vivus
Qnexa
obesity
diet pills
Arena Pharmaceuticals
FDA
Vivus Fails to Win U.S. Approval for Diet Pill Qnexa on Safety Concerns
Bloomberg
Thu, 10/28/10 - 10:17 pm
FDA
diet drugs
Qnexa
Vivus
obesity
VIVUS Shares Plunged: What You Need to Know
Motley Fool
Wed, 10/20/10 - 01:54 pm
Vivus
Qnexa
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
Why The FDA Keeps Rejecting Obesity Pills
Forbes
Mon, 10/4/10 - 05:19 pm
FDA
obesity
Arena Pharmaceuticals
Lorqess
Vivus
Qnexa
Vivus Races to Capture U.S. Approval of Obesity Drug
Seeking Alpha
Mon, 09/27/10 - 10:43 am
obesity
Vivus
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
Will the FDA Give Vivus More Time Before the Final Judgment on Qnexa?
Seeking Alpha
Sun, 09/26/10 - 12:22 pm
Qnexa
Vivus
obesity
Vivus Rallies on Positive Results for Obesity Drug
Seeking Alpha
Wed, 09/22/10 - 10:06 am
Vivus
obesity
Qnexa
Vivus: Weight Loss Extends Two Years
TheStreet.com
Tue, 09/21/10 - 12:07 pm
obesity
Vivus
Qnexa
Biotech Investor Calendar: Obesity Drugs
TheStreet.com
Tue, 09/21/10 - 12:10 pm
Vivus
Qnexa
Orexigen
obesity
Contrave
Arena Pharmaceuticals
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tue, 09/14/10 - 05:42 pm
Arena Pharmaceuticals
obesity
Takeda
Orexigen
Contrave
Abbott Laboratories
Meridia
Qnexa
Vivus
Arena Pharma Will Fail: Hedge Fund Poll
TheStreet.com
Fri, 09/10/10 - 09:32 am
Arena Pharmaceuticals
obesity
Vivus
Qnexa
Contrave
Orexigen
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »